Cargando…

Inactivation of Rbx1 E3 ligase suppresses Kras(G12D) ‐driven lung tumorigenesis

Detalles Bibliográficos
Autores principales:	Li, Yanan, Wu, Di, Li, Haomin, Sun, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353525/ https://www.ncbi.nlm.nih.gov/pubmed/37470067 http://dx.doi.org/10.1002/mco2.332

Ejemplares similares

Inactivation of Sag/Rbx2/Roc2 E3 Ubiquitin Ligase Triggers Senescence and Inhibits Kras-Induced Immortalization
por: Tan, Mingjia, et al.
Publicado: (2015)

Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis
por: Tan, Mingjia, et al.
Publicado: (2016)

SAG/RBX2 E3 Ubiquitin Ligase Differentially Regulates Inflammatory Responses of Myeloid Cell Subsets
por: Xiong, Xiufang, et al.
Publicado: (2018)

The Ube2m-Rbx1 neddylation-Cullin-RING-Ligase proteins are essential for the maintenance of Regulatory T cell fitness
por: Wu, Di, et al.
Publicado: (2022)

Transgenic expression of Sag/Rbx2 E3 causes early stage tumor promotion, late stage cytogenesis and acinar loss in the Kras–PDAC model
por: Zhang, Qiang, et al.
Publicado: (2020)

Erbin is a novel substrate of the Sag-βTrCP E3 ligase that regulates Kras(G12D)-induced skin tumorigenesis
por: Xie, Chuan-Ming, et al.
Publicado: (2015)

Fbxw7 Deletion Accelerates Kras(G12D)-Driven Pancreatic Tumorigenesis via Yap Accumulation()()()
por: Zhang, Qiang, et al.
Publicado: (2016)

Cullin 2-RBX1 E3 ligase and USP2 regulate antithrombin ubiquitination and stability
por: Xu, Dacai, et al.
Publicado: (2021)

Reduced HRAS(G12V)-Driven Tumorigenesis of Cell Lines Expressing KRAS(C118S)
por: Huang, Lu, et al.
Publicado: (2015)

Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin E
por: Hao, Jiaqing, et al.
Publicado: (2015)

RBX1/ROC1-SCF E3 ubiquitin ligase is required for mouse embryogenesis and cancer cell survival
por: Jia, Lijun, et al.
Publicado: (2009)

Endothelial deletion of Sag/Rbx2/Roc2 E3 ubiquitin ligase causes embryonic lethality and blocks tumor angiogenesis
por: Tan, Mingjia, et al.
Publicado: (2013)

Crystal Structure of the Cul2-Rbx1-EloBC-VHL Ubiquitin Ligase Complex
por: Cardote, Teresa A.F., et al.
Publicado: (2017)

Acinar-to-Ductal Metaplasia Induced by Transforming Growth Factor Beta Facilitates KRAS(G12D)-driven Pancreatic Tumorigenesis
por: Chuvin, Nicolas, et al.
Publicado: (2017)

Kras(G12D) upregulates Notch signaling to induce gallbladder tumorigenesis in mice
por: Chung, Wen-Cheng, et al.
Publicado: (2017)

Inactivation of SAG or ROC1 E3 Ligase Inhibits Growth and Survival of Renal Cell Carcinoma Cells: Effect of BIM()
por: Wang, Yu, et al.
Publicado: (2019)

Diet-Induced Unresolved ER Stress Hinders KRAS-Driven Lung Tumorigenesis
por: Ramadori, Giorgio, et al.
Publicado: (2015)

Selective targeting of KRAS-driven lung tumorigenesis via unresolved ER stress
por: Shimomura, Iwao, et al.
Publicado: (2021)

RING box protein-1(RBX1), a key component of SCF E3 ligase, induced multiple myeloma cell drug-resistance though suppressing p27
por: Bao, Enfang, et al.
Publicado: (2023)

Initiation of human mammary cell tumorigenesis by mutant KRAS requires YAP inactivation
por: Lefort, Sylvain, et al.
Publicado: (2019)

The Negative Cross-Talk between SAG/RBX2/ROC2 and APC/C E3 Ligases in Regulation of Cell Cycle Progression and Drug Resistance
por: Zhang, Shizhen, et al.
Publicado: (2020)

SAG/RBX2 is a novel substrate of NEDD4-1 E3 ubiquitin ligase and mediates NEDD4-1 induced chemosensitization
por: Zhou, Weihua, et al.
Publicado: (2014)

Circadian disruption enhances HSF1 signaling and tumorigenesis in Kras-driven lung cancer
por: Pariollaud, Marie, et al.
Publicado: (2022)

Cancer Stemness in Apc- vs. Apc/KRAS-Driven Intestinal Tumorigenesis
por: Ghazvini, Mehrnaz, et al.
Publicado: (2013)

CBX4 deletion promotes tumorigenesis under Kras(G12D) background by inducing genomic instability
por: Chen, Fangzhen, et al.
Publicado: (2023)

E3 ubiquitin ligase RBX1 drives the metastasis of triple negative breast cancer through a FBXO45-TWIST1-dependent degradation mechanism
por: Shao, Jun, et al.
Publicado: (2022)

Expression and purification of functional recombinant CUL2•RBX1 from E. coli
por: Diaz, Stephanie, et al.
Publicado: (2021)

A polydopamine nanomedicine used in photothermal therapy for liver cancer knocks down the anti-cancer target NEDD8-E3 ligase ROC1 (RBX1)
por: Zhang, Zhanxia, et al.
Publicado: (2021)

Breaking bad family ties: Pan-ERBB blockers inhibit KRAS driven lung tumorigenesis
por: Moll, Herwig P., et al.
Publicado: (2018)

STAT3 is a master regulator of epithelial identity and KRAS-driven tumorigenesis
por: D'Amico, Stephen, et al.
Publicado: (2018)

Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis
por: Best, Sarah A., et al.
Publicado: (2020)

Inactivation of TIF1γ Cooperates with Kras(G12D) to Induce Cystic Tumors of the Pancreas
por: Vincent, David F., et al.
Publicado: (2009)

SAG/RBX2 E3 ligase complexes with UBCH10 and UBE2S E2s to ubiquitylate β-TrCP1 via K11-linkage for degradation
por: Kuang, Peng, et al.
Publicado: (2016)

The Inhibition of Wnt Restrain KRAS(G12V)-Driven Metastasis in Non-Small-Cell Lung Cancer
por: Hung, Pei-Shan, et al.
Publicado: (2020)

Combined KRAS(G12C) and SOS1 inhibition enhances and extends the anti-tumor response in KRAS(G12C)-driven cancers by addressing intrinsic and acquired resistance
por: Thatikonda, Venu, et al.
Publicado: (2023)

Epithelial Tissues Have Varying Degrees of Susceptibility to Kras(G12D)-Initiated Tumorigenesis in a Mouse Model
por: Ray, Kevin C., et al.
Publicado: (2011)

AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis
por: Kim, Dae Gyu, et al.
Publicado: (2022)

E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies
por: Wang, Maoyu, et al.
Publicado: (2023)

Correction: Inactivation of TIF1γ Cooperates with Kras(G12D) to Induce Cystic Tumors of the Pancreas
por: Vincent, David F., et al.
Publicado: (2009)

Unique Pattern of Component Gene Disruption in the NRF2 Inhibitor KEAP1/CUL3/RBX1 E3-Ubiquitin Ligase Complex in Serous Ovarian Cancer
por: Martinez, Victor D., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2a8brsrb845v9ljmlsmvjjqj1d